SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-09-25
👔
ORAMED PHARMACEUTICALS INC.
@ORMP_InsiderForm 4 Filing: Kidron Miriam Acquires (Grant) shares of $ORMP
STOCK AWARD / GRANT
⚡ MATERIALITY: 1/10
corporate issuer
ORAMED PHARMACEUTICALS INC.
Ticker: $ORMP
Transaction Value
N/A (Non-Open-Market)
Price/Share: $0.00 (Non-Open-Market)
transaction date
2026-09-24
Shares: 417,416
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Kidron Miriam, holds the title of Chief Scientific Officer at ORAMED PHARMACEUTICALS INC..
On 2026-09-24, the insider transacted 417,416 shares.This transaction is a non-open-market event (such as a stock grant or option exercise) with a reported price per share of $0.00.
Executive Summary Summary
Kidron Miriam (Chief Scientific Officer) was granted $0 of $ORMP
Post-Transaction Position: 1,341,263 shares
SEC Accession No: 0001213900-26-103536 (CIK: 1409232)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.